Treating Tobacco Dependence: State of the Science and New Directions
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Despite almost two decades of intensive tobacco control efforts, nearly one quarter of Americans continue to smoke. The two United States Food and Drug Administration–approved medications used to treat tobacco dependence, bupropion and nicotine replacement therapy, are effective for only a fraction of smokers. Investigations of medications approved for affective disorders and other forms of substance abuse, such as fluoxetine and naltrexone, have yielded mixed results as tobacco dependence treatments. A particular challenge in tobacco dependence treatment is the development of effective approaches for smokers with unique needs, such as cancer patients and pregnant women. Despite new developments in these areas, significant gaps in knowledge and practice remain. Basic research in the neurobiologic and genetic basis of nicotine dependence offers promise for the development of novel and more effective treatment approaches. For example, emerging research in pharmacogenetics explores how genetic variation in drug-metabolizing enzymes and drug targets modifies response to pharmacotherapy. These discoveries could someday help practitioners to individualize the type, dosage, and duration of tobacco dependence treatment based on genotype, and maximize the efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Nicotine replacement therapy for smoking cessation
Silagy, C., Lancaster, T., Stead, L., Mant, D., & Fowler, G. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub2 · Cited by 972
Noble, E. P. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310066012 · Cited by 655
Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer
Browman, G. P., Wong, G., Hodson, I., Sathya, J., Russell, R., McAlpine, L., Skingley, P., & Levine, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280302 · Cited by 600
Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571
Self-citationThompson, J., Thomas, N., Singleton, A., Piggot, M., Lloyd, S., Perry, E. K., Morris, C. M., Perry, R. H., Ferrier, I. N., & Court, J. A. (1997) · Pharmacogenetics · doi:10.1097/00008571-199712000-00006 · Cited by 553
Genotype Influences In Vivo Dopamine Transporter Availability in Human Striatum
Heinz, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00099-8 · Cited by 538
Bupropion is a nicotinic antagonist
Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38905-0 · Cited by 509
D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes
Noble, E. P. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10005 · Cited by 501
Research works printed but not linked: 126
- 10.1093/ajhp/52.3.265 · DOI · Paper page
- 10.1001/jama.1990.03440200064024 · DOI · Paper page
- 10.1016/S0306-4603(01)00274-X · DOI
- 10.1378/chest.117.1.169 · doi:10.1378/chest.117.1.169
- 10.1136/bmj.328.7436.397 · DOI · Paper page
- 10.1037/0278-6133.12.5.399 · DOI · Paper page
- 10.1378/chest.105.2.524 · DOI
- 10.1016/S0002-9343(03)00081-0 · DOI
- 10.1001/jama.1995.03530170027027 · DOI · Paper page
- 10.1001/archinte.1991.00400040091020 · doi:10.1001/archinte.1991.00400040091020 · Paper page
- 10.1037/0022-006X.61.5.751 · doi:10.1037/0022-006x.61.5.751
- 10.1146/annurev.med.47.1.493 · DOI · Paper page
- 10.1001/jama.1989.03420090064032 · DOI · Paper page
- Silagy C, Lancaster T, Stead L, et al: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev : CD000146, 2002 · doi:10.1002/14651858.cd000146 · Paper page
- 10.1080/14622200050011303 · DOI · Paper page
- 10.1056/NEJM198801073180104 · DOI · Paper page
- 10.1016/S0095-4543(05)70121-4 · DOI
- 10.1111/j.1360-0443.2003.00575.x · DOI · Paper page
- 10.1001/jama.1994.03510480064036 · DOI · Paper page
- 10.1006/pmed.1998.0266 · DOI
- 10.1001/jama.1994.03510320035026 · DOI · Paper page
- 10.1006/pmed.1998.0391 · DOI
- 10.1056/NEJM199108013250503 · DOI · Paper page
- 10.1001/jama.1994.03510320029025 · doi:10.1001/jama.1994.03510320029025 · Paper page
- 10.1080/1462220021000018416 · DOI · Paper page
- 10.1001/jama.1995.03530170033028 · doi:10.1001/jama.1995.03530170033028 · Paper page
- Hughes JR, Lesmes GR, Hatsukami DK, et al: Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res 1:169,1999-174, · DOI · Paper page
- Silagy C, Mant D, Fowler G, et al: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev : CD000146, 2001 · doi:10.1002/14651858.cd000146 · Paper page
- 10.1001/jama.1994.03510480064036 · DOI · Paper page
- 10.1037/0893-164X.13.2.152 · DOI
- 10.1111/j.1360-0443.1995.tb01007.x · DOI
- 10.1016/S0740-5472(02)00320-3 · DOI
- 10.1111/j.1360-0443.1995.tb02837.x · doi:10.1111/j.1360-0443.1995.tb02837.x · Paper page
- 10.1016/S0025-6196(11)63642-2 · DOI
- 10.1183/09031936.97.10071585 · DOI · Paper page
- 10.1001/archinte.1994.00420220059007 · DOI
- 10.1007/BF02247430 · DOI
- 10.1080/1462220031000073252 · doi:10.1080/1462220031000073252 · Paper page
- 10.1007/s00213-003-1659-8 · DOI
- 10.1111/j.1525-1497.2003.20640.x · DOI · Paper page
- 10.1001/jama.1993.03500100066029 · DOI · Paper page
- 10.1111/j.1360-0443.1996.tb03616.x · doi:10.1111/j.1360-0443.1996.tb03616.x · Paper page
- 10.1001/archinte.1997.00440360143016 · DOI · Paper page
- 10.1007/s002130000577 · DOI
- 10.1080/1462220031000158690 · DOI · Paper page
- 10.1080/1462220031000073270 · DOI
- Ascher JA, Cole JO, Colin JN, et al: Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 56:395,1995-401,
- 10.1038/npp.1994.43 · DOI · Paper page
- 10.1023/A:1006986824213 · DOI · Paper page
- 10.1046/j.1365-2796.2003.01185.x · DOI · Paper page
- Dalsgareth OJ, Hansen NC, Soes-Petersen U, et al: A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees. Nicotine Tob Res 6:55,2004-61, · DOI · Paper page
- 10.1080/1055049029008811 · DOI · Paper page
- 10.1056/NEJM199710233371703 · DOI · Paper page
- 10.1016/S0749-3797(02)00419-1 · DOI
- 10.1080/14622200310001656830 · DOI · Paper page
- 10.1001/jama.288.4.468 · DOI · Paper page
- 10.1037/0022-006X.65.2.286 · doi:10.1037/0022-006x.65.2.286 · Paper page
- 10.1111/j.1521-0391.2003.tb00496.x · DOI · Paper page
- 10.1016/S0899-3289(88)80018-X · DOI
- Nemeth-Coslett R, Griffiths RR: Naloxone does not affect cigarette smoking. Psychopharmacology (Berl) 89:261,1986-264, · DOI
- 10.1007/s002130050756 · DOI
- 10.1007/s002130050872 · DOI
- 10.1007/BF02245813 · DOI
- David S, Lancaster T, Stead LF: Opioid antagonists for smoking cessation. Cochrane Database Syst Rev : CD003086, 2001 · DOI
- 10.1046/j.1360-0443.1999.948122713.x · DOI · Paper page
- 10.1016/S0740-5472(03)00027-8 · DOI
- 10.1300/J069v18n01_04 · DOI · Paper page
- 10.1080/14622200310001614601 · DOI · Paper page
- O'Malley S: Understanding and addressing risk factors for treatment failure. Proceedings of the 9th Annual Meeting of Society of Research in Nicotine and Tobacco 7: 2003 (abstr sym 50)
- King A, Chilton E, Hatsukami D, et al: Efficacy of naltrexone in smoking cessation: Effects of gender on clinical response. Proceedings of the 9th annual meeting of Society of Research in Nicotine and Tobacco 32: 2003 (abstr PA 8-6)
- 10.1038/sj.tpj.6500238 · DOI · Paper page
- 10.1037/1064-1297.9.4.355 · doi:10.1037/1064-1297.9.4.355
- 10.1037/0022-006X.70.4.887 · doi:10.1037/0022-006x.70.4.887 · Paper page
- 10.1093/ajcn/62.6.1181 · DOI
- 10.1046/j.1360-0443.1999.94710076.x · DOI · Paper page
- 10.1016/S0163-8343(02)00180-9 · DOI · Paper page
- 10.1038/bjc.1998.507 · DOI · Paper page
- 10.1007/BF02895166 · DOI · Paper page
- 10.1016/S0738-3991(01)00157-4 · DOI · Paper page
- 10.1002/1097-0142(20000815)89:4<881::AID-CNCR22>3.0.CO;2-M · doi:10.1002/1097-0142(20000815)89:4<881::aid-cncr22>3.0.co;2-m
- 10.1002/hed.10368 · DOI
- Stanislaw AE, Wewers ME: A smoking cessation intervention with hospitalized surgical cancer patients: a pilot study. Cancer Nurs 17:81,1994-86, · DOI · Paper page
- LeClere FB, Wilson JB: Smoking behavior of recent mothers, 18-44 years of age, before and after pregnancy: United States, 1990. Adv Data :1,1997-11, · DOI
- 10.2105/AJPH.80.5.541 · DOI · Paper page
- 10.1136/tc.9.1.16 · DOI · Paper page
- 10.1016/0306-4603(90)90020-X · DOI
- 10.1136/ewjm.174.4.276 · DOI · Paper page
- Melvin CL, Dolan-Mullen P, Windsor RA, et al: Recommended cessation counselling for pregnant women who smoke: a review of the evidence. Tob Control 9:III80,2000-III84, (suppl 3) · DOI · Paper page
- 10.2105/AJPH.87.7.1201 · DOI · Paper page
- 10.1006/pmed.1998.0287 · DOI
- 10.1016/S0749-3797(99)00071-9 · DOI · Paper page
- Benowitz NL, Dempsey DA, Goldenberg RL, et al: The use of pharmacotherapies for smoking cessation during pregnancy. Tob Control 9:III91,2000-III94, (suppl 3) · DOI · Paper page
- 10.1001/jama.1991.03470220049025 · DOI · Paper page
- 10.1126/science.286.5439.487 · DOI · Paper page
- 10.1046/j.1365-2710.2000.00281.x · DOI · Paper page
- 10.1038/sj.onc.1205801 · DOI
- 10.1097/00008571-200211000-00007 · DOI · Paper page
- 10.1097/00008571-200310000-00005 · DOI · Paper page
- 10.1016/S0028-3908(03)00136-9 · DOI · Paper page
- 10.1037/0278-6133.22.5.541 · DOI · Paper page
- 10.1097/00008571-199602000-00006 · DOI · Paper page
- 10.1037/0278-6133.18.1.14 · doi:10.1037/0278-6133.18.1.14 · Paper page
- 10.1037/0278-6133.18.1.7 · doi:10.1037/0278-6133.18.1.7 · Paper page
- 10.1093/jnci/90.5.358 · DOI · Paper page
- 10.1038/oby.2002.168 · DOI · Paper page
- 10.1016/0006-8993(96)00068-6 · DOI
- 10.1002/gepi.1370170707 · DOI · Paper page
- 10.1097/00008571-199412000-00004 · DOI · Paper page
- 10.1517/14622416.1.3.309 · DOI · Paper page
- 10.1038/sj.tpj.6500026 · DOI · Paper page
- 10.1080/14622200310001615295 · DOI · Paper page
- 10.1080/14622200410001676396 · DOI · Paper page
- Lerman C, Berrettini W, Pinto A, et al: Changes in food reward following smoking cessation: a pharmacogenetic investigation. Psychopharmacology (Berl) 174:571,2004-577, · DOI · Paper page
- 10.1097/00008571-200402000-00002 · DOI · Paper page
- 10.1136/bmj.38050.674826.AE · DOI · Paper page
- 10.2174/1568007023339076 · DOI · Paper page
- 10.1038/sj.tpj.6500238 · DOI · Paper page
- 10.1038/386499a0 · DOI · Paper page
- 10.1016/0304-3940(90)90491-Q · DOI
- 10.1073/pnas.95.16.9608 · DOI · Paper page
- 10.1097/00041444-200309000-00006 · DOI · Paper page
- 10.1007/s00213-003-1637-1 · DOI
- 10.1093/alcalc/37.5.495 · DOI · Paper page
- 10.1124/jpet.303.2.664 · DOI
- 10.1016/S0893-133X(02)00349-4 · DOI
- 10.1080/14622200410001734058 · doi:10.1080/14622200410001734058
Cited by
Effectiveness of brief alcohol interventions in primary care populations
Kaner, E. F., Beyer, F. R., Muirhead, C., Campbell, F., Pienaar, E. D., Bertholet, N., Daeppen, J. B., Saunders, J. B., & Burnand, B. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004148.pub4 · Cited by 1,665
Nicotine and nonnicotine factors in cigarette addiction
Rose, J. E. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0250-x · Cited by 349
Brief meditation training induces smoking reduction
Tang, Y.-Y., Tang, R., & Posner, M. I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311887110 · Cited by 202
Diretrizes para cessação do tabagismo - 2008
Reichert, J., Araújo, A. J. D., Gonçalves, C. M. C., Godoy, I., Chatkin, J. M., Sales, M. D. P. U., & Santos, S. R. R. D. A. (2008) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132008001000014 · Cited by 166
Cessation in the use of tobacco – pharmacologic and non‐pharmacologic routines in patients
Quist‐Paulsen, P. (2008) · The Clinical Respiratory Journal · doi:10.1111/j.1752-699x.2007.00038.x · Cited by 12
Metadata
- Authors
- Lerman, C., Patterson, F., & Berrettini, W.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-01-10
- Volume
- 23
- Issue
- 2
- Pages
- 311-323
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2028564423
- Cited by
- 88
- References
- 32
- FWCI
- 11.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.